159 related articles for article (PubMed ID: 1713357)
1. Vasoactive intestinal polypeptide inhibits c-myc expression and growth of human gastric carcinoma cells.
Kim SW; Beauchamp RD; Townsend CM; Thompson JC
Surgery; 1991 Aug; 110(2):270-5; discussion 276. PubMed ID: 1713357
[TBL] [Abstract][Full Text] [Related]
2. Effect of vasoactive intestinal peptide on gastric adenocarcinoma.
Li GH; Qian W; Song GQ; Hou XH
J Gastroenterol Hepatol; 2007 Aug; 22(8):1328-35. PubMed ID: 17559364
[TBL] [Abstract][Full Text] [Related]
3. Regulation of prostate-specific antigen (PSA) gene expression and release in LNCaP prostate cancer by antagonists of growth hormone-releasing hormone and vasoactive intestinal peptide.
Rekasi Z; Schally AV; Plonowski A; Czompoly T; Csernus B; Varga JL
Prostate; 2001 Aug; 48(3):188-99. PubMed ID: 11494334
[TBL] [Abstract][Full Text] [Related]
4. Non-steroidal anti-inflammatory drug-induced apoptosis in gastric cancer cells is blocked by protein kinase C activation through inhibition of c-myc.
Zhu GH; Wong BC; Eggo MC; Ching CK; Yuen ST; Chan EY; Lai KC; Lam SK
Br J Cancer; 1999 Feb; 79(3-4):393-400. PubMed ID: 10027304
[TBL] [Abstract][Full Text] [Related]
5. Vasoactive intestinal peptide and forskolin regulate proliferation of the HT29 human colon adenocarcinoma cell line.
Gamet L; Murat JC; Remaury A; Remesy C; Valet P; Paris H; Denis-Pouxviel C
J Cell Physiol; 1992 Mar; 150(3):501-9. PubMed ID: 1371513
[TBL] [Abstract][Full Text] [Related]
6. Cyclic AMP-mediated suppression of normal and neoplastic B cell proliferation is associated with regulation of myc and Ha-ras protooncogenes.
Blomhoff HK; Smeland EB; Beiske K; Blomhoff R; Ruud E; Bjøro T; Pfeifer-Ohlsson S; Watt R; Funderud S; Godal T
J Cell Physiol; 1987 Jun; 131(3):426-33. PubMed ID: 3036888
[TBL] [Abstract][Full Text] [Related]
7. Vasoactive intestinal peptide (VIP) stimulates in vitro growth of VIP-1 receptor-bearing human pancreatic adenocarcinoma-derived cells.
Jiang S; Kopras E; McMichael M; Bell RH; Ulrich CD
Cancer Res; 1997 Apr; 57(8):1475-80. PubMed ID: 9108448
[TBL] [Abstract][Full Text] [Related]
8. Vasoactive intestinal peptide receptor regulation and reversible desensitization in human colonic carcinoma cells in culture.
Boissard C; Marie JC; Hejblum G; Gespach C; Rosselin G
Cancer Res; 1986 Sep; 46(9):4406-13. PubMed ID: 3015387
[TBL] [Abstract][Full Text] [Related]
9. Cyclic AMP-dependent protein kinase in Molt 4b lymphoblasts: identification by photoaffinity labeling and activation in intact cells by vasoactive intestinal polypeptide (VIP) and peptide histidine isoleucine (PHI).
O'Dorisio MS; Wood CL; Wenger GD; Vassalo LM
J Immunol; 1985 Jun; 134(6):4078-86. PubMed ID: 2985703
[TBL] [Abstract][Full Text] [Related]
10. cAMP activation by PACAP/VIP stimulates IL-6 release and inhibits osteoblastic differentiation through VPAC2 receptor in osteoblastic MC3T3 cells.
Nagata A; Tanaka T; Minezawa A; Poyurovsky M; Mayama T; Suzuki S; Hashimoto N; Yoshida T; Suyama K; Miyata A; Hosokawa H; Nakayama T; Tatsuno I
J Cell Physiol; 2009 Oct; 221(1):75-83. PubMed ID: 19496170
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer growth is inhibited by vasoactive intestinal peptide (VIP) hybrid, a synthetic VIP receptor antagonist.
Zia H; Hida T; Jakowlew S; Birrer M; Gozes Y; Reubi JC; Fridkin M; Gozes I; Moody TW
Cancer Res; 1996 Aug; 56(15):3486-9. PubMed ID: 8758916
[TBL] [Abstract][Full Text] [Related]
12. Vasoactive intestinal peptide (VIP) stimulates rat prostatic epithelial cell proliferation.
Juarranz MG; Bodega G; Prieto JC; Guijarro LG
Prostate; 2001 Jun; 47(4):285-92. PubMed ID: 11398176
[TBL] [Abstract][Full Text] [Related]
13. Human H9 cells proliferation is differently controlled by vasoactive intestinal peptide or peptide histidine methionine: implication of a GTP-insensitive form of VPAC1 receptor.
Goursaud S; Pineau N; Becq-Giraudon L; Gressens P; Muller JM; Janet T
J Neuroimmunol; 2005 Jan; 158(1-2):94-105. PubMed ID: 15589042
[TBL] [Abstract][Full Text] [Related]
14. Vasoactive intestinal polypeptide and alpha 2-adrenoceptor agonists regulate adenosine 3',5'-monophosphate accumulation and melatonin release in chick pineal cell cultures.
Pratt BL; Takahashi JS
Endocrinology; 1989 Nov; 125(5):2375-84. PubMed ID: 2477231
[TBL] [Abstract][Full Text] [Related]
15. Mad1 expression in the absence of differentiation: effect of cAMP on the B-lymphoid cell line Reh.
Naderi S; Blomhoff HK
J Cell Physiol; 1999 Jan; 178(1):76-84. PubMed ID: 9886493
[TBL] [Abstract][Full Text] [Related]
16. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide prevent inducible nitric oxide synthase transcription in macrophages by inhibiting NF-kappa B and IFN regulatory factor 1 activation.
Delgado M; Munoz-Elias EJ; Gomariz RP; Ganea D
J Immunol; 1999 Apr; 162(8):4685-96. PubMed ID: 10202009
[TBL] [Abstract][Full Text] [Related]
17. A mechanistic study of cigarette smoke and cyclooxygenase-2 on proliferation of gastric cancer cells.
Shin VY; Liu ES; Ye YN; Koo MW; Chu KM; Cho CH
Toxicol Appl Pharmacol; 2004 Feb; 195(1):103-12. PubMed ID: 14962510
[TBL] [Abstract][Full Text] [Related]
18. Expression of hepatocyte growth factor is up-regulated through activation of a cAMP-mediated pathway.
Matsunaga T; Gohda E; Takebe T; Wu YL; Iwao M; Kataoka H; Yamamoto I
Exp Cell Res; 1994 Feb; 210(2):326-35. PubMed ID: 7507855
[TBL] [Abstract][Full Text] [Related]
19. Regulation of proliferation in a murine colony-stimulating factor-dependent myeloid cell line: superinduction of c-fos by the growth inhibitor 8-Br-cyclic adenosine 3':5' monophosphate.
Harel-Bellan A; Farrar WL
J Cell Biochem; 1988 Nov; 38(3):145-53. PubMed ID: 3068231
[TBL] [Abstract][Full Text] [Related]
20. Cyclic AMP in ovarian cancer cells both inhibits proliferation and increases c-KIT expression.
Shaw TJ; Keszthelyi EJ; Tonary AM; Cada M; Vanderhyden BC
Exp Cell Res; 2002 Feb; 273(1):95-106. PubMed ID: 11795950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
